(Q51642139)

English

Is radioembolization ready for the barcelona clinic liver cancer staging system?

scientific article published in November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

0 references

Is radioembolization ready for the barcelona clinic liver cancer staging system? (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Laura Kulik

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

52

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

5

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

1528-1530

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

NCCN clinical practice guidelines in oncology: hepatobiliary cancers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24030

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24030

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

release_2fs4tp4qovfjjcryy7gdi5lf5y

1 reference

https://api.fatcat.wiki/v0/release/2fs4tp4qovfjjcryy7gdi5lf5y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21038408

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51642139&oldid=1836050227"